Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer
- PMID: 10697621
Serum type I collagen degradation markers, ICTP and CrossLaps, are factors for poor survival in lung cancer
Abstract
We investigated the prognostic value of the serum markers of type I collagen synthesis (PINP and PICP) and degradation (ICTP and CrossLaps) in 143 lung cancer patients with a local or locally advanced disease or a metastatic disease. The mean values of ICTP, CrossLaps, PINP and PICP were significantly higher in patients with bone metastases than in those without metastases or with only soft tissue metastases. The patients with ICTP < or = 5.0 micrograms/l or CrossLaps < or = 5000 pmol/l had a better prognosis. The histopathological type, the site of metastases or the stage of the disease had no influence on these results. In multivariate regression analysis, both ICTP and CrossLaps in contrast to PINP or PICP, were prognostic factors for poor survival in lung cancer patients. ICTP, CrossLaps, sedimentation rate, hemoglobin and AFOS reached separately weaker, but statistically significant values as predictors of survival with stage and operation.
Similar articles
-
Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.Clin Cancer Res. 2001 Jun;7(6):1633-7. Clin Cancer Res. 2001. PMID: 11410500
-
Type I collagen metabolites as tumor markers in patients with lung carcinoma.Cancer. 1999 May 1;85(9):1951-7. Cancer. 1999. PMID: 10223235
-
Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.Anticancer Res. 1996 Jul-Aug;16(4B):2289-93. Anticancer Res. 1996. PMID: 8694558
-
[Carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP)].Nihon Rinsho. 2000 Jul;58 Suppl:163-5. Nihon Rinsho. 2000. PMID: 11022707 Review. Japanese. No abstract available.
-
Monitoring tissue repair and fibrosis from a distance.Circulation. 1997 Oct 21;96(8):2488-92. Circulation. 1997. PMID: 9355880 Review. No abstract available.
Cited by
-
Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.Cancer Med. 2014 Oct;3(5):1136-45. doi: 10.1002/cam4.303. Epub 2014 Jul 18. Cancer Med. 2014. PMID: 25044252 Free PMC article.
-
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Assay Drug Dev Technol. 2013 Mar;11(2):70-92. doi: 10.1089/adt.2012.474. Epub 2012 Oct 9. Assay Drug Dev Technol. 2013. PMID: 23046407 Free PMC article. Review.
-
Preoperative anemia as a prognostic factor in patients with lung cancer: a systematic review and meta-analysis of epidemiological studies.J Cancer. 2019 May 12;10(9):2047-2056. doi: 10.7150/jca.29410. eCollection 2019. J Cancer. 2019. PMID: 31205565 Free PMC article.
-
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Arthritis Res Ther. 2011 Apr 28;13(2):215. doi: 10.1186/ar3280. Arthritis Res Ther. 2011. PMID: 21539724 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical